HLS Return On Assets from 2010 to 2026

HLS Stock  CAD 4.40  0.11  2.56%   
This page tracks HLS Therapeutics's Return On Assets across reporting periods, highlighting trend direction and inflection points. This page presents HLS Therapeutics's Return On Assets as reference data drawn from available financial statements. Long-term reporting places Return On Assets within a compressing cycle. Return On Assets is a profitability ratio that indicates the percentage of profit HLS Therapeutics earns in relation to its overall resources. It is calculated by dividing net income by total assets. Complete Financial Overview
 
Return On Assets  
 First Reported
2010-12-31
 Previous Quarter
-0.09
 Current Value
-0.09
 Quarterly Volatility
0.17056336
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Evaluating HLS Therapeutics's Return On Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into HLS Therapeutics's fundamental strength.

Latest HLS Therapeutics' Return On Assets Growth Pattern

Below is the plot of the Return On Assets of HLS Therapeutics over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. HLS Therapeutics' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HLS Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Slightly volatile
   Return On Assets   
       Timeline  

HLS Return On Assets Regression Statistics

Arithmetic Mean 0.03
Geometric Mean 0.1
Coefficient Of Variation 608.34
Mean Deviation 0.14
Median-0.05
Standard Deviation 0.17
Sample Variance 0.03
Range0.5067
R-Value-0.85
Mean Square Error 0.01
R-Squared 0.73
Significance 0.000014
Slope-0.03
Total Sum of Squares 0.47

HLS Return On Assets History

2026 -0.0875
2025 -0.0921
2024 -0.12
2023 -0.13
2022 -0.0977
2021 -0.0475
2020 -0.0504

Methodology, Assumptions & Data Sources

Historical Return On Assets reference data for HLS Therapeutics helps separate noise from meaningful trend changes. Year-over-year changes are useful for detecting inflection points.

The analytics block for HLS Therapeutics relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on March 7th, 2026